OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC
Sandra Huber, Constance Baer, Stephan Hütter, et al.
Leukemia (2023) Vol. 37, Iss. 10, pp. 2138-2141
Open Access | Times Cited: 6
Sandra Huber, Constance Baer, Stephan Hütter, et al.
Leukemia (2023) Vol. 37, Iss. 10, pp. 2138-2141
Open Access | Times Cited: 6
Showing 6 citing articles:
Immunotherapeutic Potential of Mutated NPM1 for the Treatment of AML
Jochen Greiner, Eithar Mohamed, Daniel Fletcher, et al.
(2024)
Open Access | Times Cited: 1
Jochen Greiner, Eithar Mohamed, Daniel Fletcher, et al.
(2024)
Open Access | Times Cited: 1
Immunotherapeutic Potential of Mutated NPM1 for the Treatment of Acute Myeloid Leukemia
Jochen Greiner, Eithar Mohamed, Daniel Fletcher, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3443-3443
Open Access | Times Cited: 1
Jochen Greiner, Eithar Mohamed, Daniel Fletcher, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3443-3443
Open Access | Times Cited: 1
Phase to phase: Navigating drug combinations with hypomethylating agents in higher-risk MDS trials for optimal outcomes
Almuth Maria Anni Merz, Marie Sébert, Jan Sonntag, et al.
Cancer Treatment Reviews (2023) Vol. 123, pp. 102673-102673
Closed Access | Times Cited: 4
Almuth Maria Anni Merz, Marie Sébert, Jan Sonntag, et al.
Cancer Treatment Reviews (2023) Vol. 123, pp. 102673-102673
Closed Access | Times Cited: 4
Practical considerations in clinical application of WHO 5th and ICC classification schemes for acute myeloid leukemia
Daniel J. Chandra, Curtis A. Lachowiez, Sanam Loghavi
Blood Reviews (2023) Vol. 64, pp. 101156-101156
Closed Access | Times Cited: 3
Daniel J. Chandra, Curtis A. Lachowiez, Sanam Loghavi
Blood Reviews (2023) Vol. 64, pp. 101156-101156
Closed Access | Times Cited: 3
MicroRΝΑ analysis in patients with myelodysplastic neoplasms. Possible implications in risk stratification
Stavroula Syriopoulou, Christina‐Nefeli Kontandreopoulou, Panagiotis Diamantopoulos, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-7
Closed Access
Stavroula Syriopoulou, Christina‐Nefeli Kontandreopoulou, Panagiotis Diamantopoulos, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-7
Closed Access
Mutation- and MRD-informed treatment decisions for the transplant-eligible AML patient
Michael Heuser, Rabia Shahswar
Hematology (2024) Vol. 2024, Iss. 1, pp. 158-167
Closed Access
Michael Heuser, Rabia Shahswar
Hematology (2024) Vol. 2024, Iss. 1, pp. 158-167
Closed Access
